Cargando…
Phase- and gender-specific, lifetime, and future costs of cancer: A retrospective population-based registry study
Valid estimates of cancer treatment costs are import for priority setting, but few studies have examined costs of multiple cancers in the same setting. We performed a retrospective population-based registry study to evaluate phase-specific (initial, continuing, and terminal phase) direct medical cos...
Autores principales: | Bugge, Christoffer, Brustugun, Odd Terje, Sæther, Erik Magnus, Kristiansen, Ivar Sønbø |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8257845/ https://www.ncbi.nlm.nih.gov/pubmed/34190187 http://dx.doi.org/10.1097/MD.0000000000026523 |
Ejemplares similares
-
What are determinants of utilisation of pharmaceutical anticancer treatment during the last year of life in Norway? A retrospective registry study
por: Bugge, Christoffer, et al.
Publicado: (2021) -
Diagnosing heart failure with NT-proBNP point-of-care testing: lower costs and better outcomes. A decision analytic study
por: Bugge, Christoffer, et al.
Publicado: (2018) -
Effect of a pharmacist‐led intervention on adherence among patients with a first‐time prescription for a cardiovascular medicine: a randomized controlled trial in Norwegian pharmacies
por: Hovland, Ragnar, et al.
Publicado: (2019) -
Modeling the cost of influenza: the impact of missing costs of unreported complications and sick leave
por: Xue, Yiting, et al.
Publicado: (2010) -
Gaps and discontinuation of statin treatment in Norway: potential for optimizing management of lipid lowering drugs
por: Engebretsen, Ingrid, et al.
Publicado: (2022)